CVS Group plc (LON:CVSG)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 898.00M |
| Revenue (ttm) | 692.80M |
| Net Income (ttm) | 49.40M |
| Shares Out | 70.16M |
| EPS (ttm) | 0.69 |
| PE Ratio | 55.89 |
| Forward PE | 14.03 |
| Dividend | 0.09 (0.66%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 197,129 |
| Average Volume | 266,019 |
| Open | 1,292.00 |
| Previous Close | 1,278.00 |
| Day's Range | 1,264.00 - 1,302.00 |
| 52-Week Range | 885.00 - 1,648.00 |
| Beta | 1.03 |
| RSI | 35.56 |
| Earnings Date | Feb 26, 2026 |
About CVS Group
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, ... [Read more]
Financial Performance
In fiscal year 2025, CVS Group's revenue was 673.20 million, an increase of 5.40% compared to the previous year's 638.70 million. Earnings were 52.80 million, an increase of 751.61%.
Financial StatementsNews
CVS Group plc (CVSGF) Shareholder/Analyst Call Transcript
CVS Group plc (CVSGF) Shareholder/Analyst Call March 4, 2026 11:00 AM ESTCompany ParticipantsRichard William Fairman - CEO & DirectorRobin Alfonso - CFO...
CVS Group PLC (FRA:4C9) (H1 2026) Earnings Call Highlights: Strong Revenue Growth Amid Market ...
CVS Group PLC (FRA:4C9) (H1 2026) Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
Half Year 2026 CVS Group PLC Earnings Call Transcript
Half Year 2026 CVS Group PLC Earnings Call Transcript
CVS Group plc (CVSGF) Q2 2026 Earnings Call Prepared Remarks Transcript
CVS Group plc (CVSGF) Q2 2026 Earnings Call February 25, 2026 7:00 PM ESTCompany ParticipantsRichard William Fairman - CEO & DirectorRobin Alfonso - CFO...
CVS Group plc 2026 Q2 - Results - Earnings Call Presentation
CVS Group PLC (FRA:4C9) Half Year 2026 Earnings Call Highlights: Strategic Expansion and ...
CVS Group PLC (FRA:4C9) Half Year 2026 Earnings Call Highlights: Strategic Expansion and Resilience Amidst Economic Challenges
Half Year 2026 CVS Group PLC Earnings Call-Q&A Transcript
Half Year 2026 CVS Group PLC Earnings Call-Q&A Transcript
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Gabelli Pet Parents' Fund’s Q3’s largest contributors included Chewy Inc., Zoetis Inc., and Freshpet Inc. Largest detractors were Trupanion Inc., Petco Health & Wellness, and CVS Group plc.
UK's CVS Group plans Main Market move, approves near $27 million buyback
Veterinary services provider CVS Group said on Friday it plans to move its listing from the Alternative Investment Market to the London Stock Exchange's Main Market, while also approving a new 20 mill...
CVS Group plc (CVSGF) Q4 2025 Earnings Call Prepared Remarks Transcript
CVS Group plc (OTCPK:CVSGF) Q4 2025 Earnings Call October 6, 2025 8:00 PM EDT Company Participants Richard William Fairman - CEO & Director Robin Alfonso - CFO & Director Paul Higgs - Chief Veterinary...
CVS Group plc (CVSGF) Q4 2025 Earnings Call Transcript
CVS Group plc (OTCPK:CVSGF) Q4 2025 Earnings Call October 7, 2025 4:00 AM EDT Company Participants Richard William Fairman - CEO & Director Robin Alfonso - CFO & Director Paul Higgs - Chief Veterinary...
Intel faces possible split, CVS group president: Market Domination
There's just one more hour to go in Tuesday's trading day, Julie Hyman and Alexandra Canal are here to cover the day's biggest market stories and speak to Wall Street experts on today's Market Dominat...